Organization type
- Contract research organization (CRO)
 
Early phases
- Biomarker identification
 - Target identification – new biological hypothesis
 - Target validation – Hypothesis verification
 
Screening
- 
			Assay development
			
- In vivo screening models
 
 - 
			Chemical libraries
			
- Functional genomics libraries
 - Natural product extracts: plants, microbial, animal (invertebrates, insects)
 - Small molecules (including natural product, DNA encoded libraries and fragment libraries)
 
 - Screening and high throughput screening using small molecules (including natural product, DNA encoded libraries and fragment libraries)
 
Optimization phases
- In vivo animal models (including assay/model development and testing)
 - 
			Preclinical phase (including assay/model development and testing)(non-regulatory and regulatory)
			
- Safety
 - Toxicology
 
 
Terapeutic areas
- Autoimmunity / Inflammation
 - Cancer
 - Cardiovascular
 - Dermatology
 - Infectious diseases
 - Nervous Central System
 - Ophthalmology / Optometry
 - Rare diseases
 
Additional activities
- CROs providing no-regulatory and regulatory services for drug discovery
 
			


